Clinical Trial Update: Personalized Ultra-fractionated Stereotactic Adaptive Radiotherapy for Metastatic Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for personalized ultra-fractionated stereotactic adaptive radiotherapy in metastatic cervical cancer; the study is currently activ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenosquamous Carcinoma of the Cervix
• Cervical Cancer

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Stage IV Cervical Cancer FIGO 2018, Adenosquamous Carcinoma of Cervix | Phase 2 | Status: ACTIVE_NOT_RECRUITING